Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials

Authors:

Abstract
OBJECTIVES:Two identical, phase 3, randomized, double-blind, placebo-controlled trials evaluated the efficacy and safety of plecanatide in patients with irritable bowel syndrome with constipation (IBS-C).METHODS:Adults meeting Rome III criteria for IBS-C were randomized (1:1:1) to placebo or plecana

This publication has 30 references indexed in Scilit: